ALZAMEND NEURO INC (ALZN) Stock Income Statement
NASDAQ:ALZN - Nasdaq - US02262M5067 - Common Stock - Currency: USD
| TTM (2025-1-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 4.21M | 9.94M | 14.87M | 12.32M | 4.95M | |||
| Research and Development | 1.15M | 6.46M | 7.45M | 5.20M | 1.31M | |||
| Selling, General, and Administrative Expenses | 3.06M | 3.48M | 7.42M | 7.12M | 3.64M | |||
| Operating Income | -4.21M | -9.94M | -14.87M | -12.32M | -4.95M | |||
| Interest Income/Expense | -19.00K | -10.10K | -10.00K | -50.00K | -160.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | 0.00 | 60.00K | |||
| Income Before Taxes | -4.23M | -9.95M | -14.88M | -12.36M | -5.05M | |||
| Net Income | -4.28M | -9.95M | -14.88M | -12.36M | -5.05M | |||
| EBITDA | -4.16M | -9.89M | -14.85M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -17.81 | -132.33 | -2.29 | -2.08 | -0.89 | |||
| Non GAAP EPS | -19.73 | -27.55 | -22.50 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD